The Predictor Factors Causing Length of Stay (LOS) in Diabetic Neuropathy Patients
Keywords:
DM Neuropathy, Length of Stay, Predictor factorsAbstract
Diabetes mellitus has emerged as a prevalent public health issue, experiencing a steady rise across the globe, in both developed and developing nations. Among the chronic complications frequently observed in diabetic individuals is diabetic neuropathy, characterized by recurrent infections, non-healing ulcers, and the potential for finger or toe amputations. These neuropathic complications often prolong the treatment duration, consequently impacting the length of hospitalization for patients. Neuropathic conditions in Type 2 Diabetes Mellitus (DM) result in a prolonged healing process. This research aims to analyze the predictor factors contributing to the Length of Stay (LOS) in neuropathic DM patients. It employs a quantitative research approach utilizing a descriptive correlation methodology. The research was conducted from October 2023 to February 2024 at Indriati Solo Baru Hospital, with a questionnaire serving as the research instrument. The sample in this research comprised patients with Diabetic Neuropathy (DM Neuropathy) selected using the Purposive Sampling technique and totaled 127 respondents. Data analysis included univariate, bivariate, and multivariate analyses. The outcomes revealed that out of the seven factors examined, only three factors were significantly associated with the Length of Stay (LOS) among neuropathic DM patients: control of blood sugar levels, presence of complications in respondents, and presence of comorbid diseases in respondents. The predictor factor that exerted the greatest influence on the Length of Stay (LOS) level in neuropathic DM patients was the presence of comorbid diseases in respondents. The study primarily focuses on identifying predictor factors for length of stay (LOS) in neuropathic DM patients. However, it did not thoroughly control for potential confounding variables that could influence LOS, such as socioeconomic status, access to healthcare, severity of neuropathy, and presence of other comorbidities aside from diabetes. suggestion to the next research to focus on other variables such as healthcare, the severity of neuropathy, and the presence of other comorbidities aside from diabetes.
References
Simanjuntak GV, Simamora M. Lama menderita diabetes mellitus tipe 2 sebagai faktor risiko neuropati perifer diabetik. Holistik J Kesehat. 2020;14(1):96–100.
Park JH, Kim DS. The necessity of the simple tests for diabetic peripheral neuropathy in type 2 diabetes mellitus patients without neuropathic symptoms in clinical practice. Diabetes Metab J. 2018;42(5):442–6.
Bakara DM, Khoirini F, Manik MJ. The Effect of Neuropathic Exercise on HbA1c Value in Patients with Type 2 Diabetes Mellitus. Int J Nurs Educ. 2023;15(4):4–9.
Simbolon P, Ibrahim H. Risk Factors that Influence Hospital Length of Stay in Diabetic Foot Ulcer with Negative Pressure Wound Therapy at RS. dr. Cipto Mangunkusumo. New Ropanasuri J Surg. 2020;5(1):20–4.
Lubis IKS. Analisis Length Of Stay (LOS) Berdasarkan Faktor Prediktor Pada Pasien DM Tipe II di RS PKU Muhammadiyah Yogyakarta. J Kesehat Vokasional. 2017;2(2):161–6.
Amiman RC, Tumboimbela MJ, Kembuan MAHN. Gambaran length of stay pada pasien stroke rawat inap di RSUP Prof. Dr. R. D. Kandou Manado periode Juli 2015-Juni 2016. e-CliniC. 2016;4(2).
Bala C, Rusu A, Ciobanu D, Roman G. Length of Hospital Stay, Hospitalization Costs, and Their Drivers in Adults with Diabetes in the Romanian Public Hospital System. Int J Environ Res Public Health. 2022;19(16).
Lubis IK, Susilawati S. Analisis Length Of Stay (Los) Berdasarkan Faktor Prediktor Pada Pasien DM Tipe II di RS PKU Muhammadiyah Yogyakarta. J Kesehat Vokasional. 2018;2(2):161.
Mildawati, Diani N, Wahid A. Hubungan Usia, Jenis Kelamin dan Lama Menderita Diabetes dengan Kejadian Neuropati Perifer Diabateik. Caring Nurs J. 2019;3(2):31–7.
Shamim A, Haq A, Ali M. Prevalence of peripheral diabetic neuropathy and its association with patients related factors. Pakistan J Med Heal Sci. 2017;11(3):1130–2.
Kamenov ZA, Rumyana AP, Rumyana TG. Earlier Development of Diabetic Neuropathy in Men Than in Women with Type 2 Diabetes Mellitus. Gend Med. 2012;7(6):600–15.
Putri AM, Hasneli Y, Safri. Faktor-Faktor Yang Mempengaruhi Derajat Keparahan Neuropati Perifer Pada Pasien Diabetes Melitus : Literature Review. J Ilmu Keperawatan. 2020;8(1):38–53.
Tofure IR, Huwae L, Astuty E. Karakteristik pasien penderita neuropati perifer diabetik di poli klinik saraf. Molucca Medica. 2021;14(2):97–108.
NIȚĂ G, GHERASIM A, NIȚĂ O, POPA AD, ARHIRE LI, MIHALACHE L, et al. Factors influencing length of hospital stay in patients with diabetic foot ulcers. Rom J Med Pract. 2021;16(2):234–40.
Kebede SA, Tusa BS, Weldesenbet AB, Tessema ZT, Ayele TA. Time to diabetic neuropathy and its predictors among newly diagnosed type 2 diabetes mellitus patients in Northwest Ethiopia. Egypt J Neurol Psychiatry Neurosurg [Internet]. 2021;57(1). Available from: https://doi.org/10.1186/s41983-021-00402-4
Salim MF, Lubis IK, Sugeng S. Perbedaan Length of Stay (LOS) Pasien Diabetes Mellitus Berdasarkan Komplikasi Di RSUP Dr. Sardjito Yogyakarta. J Manaj Inf Kesehat Indones. 2019;7(1):17.
Andersson E, Persson S, Hallén N, Ericsson Å, Thielke D, Lindgren P, et al. Costs of diabetes complications: Hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden. Diabetologia. 2020;63:2582–2594.
Friel K., Gillespie P, Coates V, McCauley C, McCann M, O’Kane M, et al. Estimating and examining the costs of inpatient diabetes care in an Irish Public Hospital. Diabet. Med. 2021;28.
Cheng S., Wang C., Ko Y. Costs and Length of Stay of Hospitalizations due to Diabetes-Related Complications. Diabetes Res. 2019;
Rosyid FN, Prasetyo TA, Safitri L. Correlation of Peripheral Vascular Status with Quality of Life Type 2 Diabetes Mellitus Patients (Measured By Ankle Brachial Value Index). 2017;3(Inc):98–100.
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Ziegler D. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1).
Nur Rosyid F, Heri Nugroho H S K, . M, . S. Glycated Albumin Value and Its Relation with The Improvement of Diabetic Ulcers: Pilot Study. KnE Soc Sci. 2023;2023:763–71.
Darwis P, Simanjuntak BH, Wangge G, Pratama D, Bakri A, Telaumbanua R. Factors Affecting Hospital Length of Stay in Patient with Diabetic Foot Ulcer. J llmu Bedah Indones. 2019;47(2):3–16.
Rosyid FN. Knowledge of diabetic ulcers and foot care in patients with type 2. 2021;
Cahyono TD, Purwanti OS. Hubungan Antara Lama Menderita Diabetes Dengan Nilai Ankle Brachial Index. J Ber Ilmu Keperawatan. 2019;12(2):65–71.
Published
How to Cite
Issue
Section
Authors who publish with Poltekita : Jurnal Ilmu Kesehatan agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
This work is licensed under a Creative Commons Attribution-ShareAlike 2.0 Generic License.
Poltekita : Jurnal Ilmu Kesehatan is licensed under a Creative Commons Attribution-Share Alike 4.0 International License
You are free to:
- Share, copy and redistribute the material in any medium or format
- Adapt, remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
